Validation of Rapid Antibody (IgM – IgG) Test Kit for SARS-CoV-2 Infection in Surabaya, Indonesia
At the beginning of the Corona Virus Disease 2019 (COVID-19) pandemic, rapid test examinations were widely used as a screening for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. The purpose of this examination was to detect SARS-CoV-2 IgM/IgG antibodies in the patient'...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Nahdlatul Ulama Surabaya
2022-10-01
|
| Series: | Indonesian Journal of Medical Laboratory Science and Technology |
| Subjects: | |
| Online Access: | https://journal2.unusa.ac.id/index.php/IJMLST/article/view/3027 |
| _version_ | 1811190940045410304 |
|---|---|
| author | Museyaroh Museyaroh Puspa Wardani Aryati Aryati Evy Diah Woelansari |
| author_facet | Museyaroh Museyaroh Puspa Wardani Aryati Aryati Evy Diah Woelansari |
| author_sort | Museyaroh Museyaroh |
| collection | DOAJ |
| description |
At the beginning of the Corona Virus Disease 2019 (COVID-19) pandemic, rapid test examinations were widely used as a screening for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. The purpose of this examination was to detect SARS-CoV-2 IgM/IgG antibodies in the patient's body. One of these tests uses the immunochromatographic method. This study aims to determine the validity of immunochromatography. The study was conducted from August to September 2020. The sample used in this study was 100 patients. The research was conducted at Husada Utama Hospital Surabaya, Indonesia. According to the study's findings, the Zybio brand reagent kit has an accuracy of 85%, a sensitivity of 82%, a specificity of 88%, a positive predictive value of 87%, and a negative predictive value of 83%. In the group of patients who experienced clinical symptoms, < 7 had a sensitivity of 50%, specificity of 88%, positive predictive value of 60%, negative predictive value of 83%, and accuracy of 77.94% while the group of patients experiencing clinical symptoms > 7 days, had a sensitivity value of 100 %, specificity of 88%, positive predictive value of 84%, negative predictive value of 100%, and accuracy of 92.68%. Based on these results, the conclusion is that the Zybio brand reagent kit has a relatively high sensitivity, specificity, positive predictive value, negative value, and sample accuracy. In the group with clinical sensitivity < 7 days, the positive predictive value and accuracy are lower than the sample group with clinical symptoms > 7 days but have the same specificity.
|
| first_indexed | 2024-04-11T14:58:44Z |
| format | Article |
| id | doaj.art-d2d280ce1ccf49fabae5ab0cb0f233c5 |
| institution | Directory Open Access Journal |
| issn | 2684-6748 2656-9825 |
| language | English |
| last_indexed | 2024-04-11T14:58:44Z |
| publishDate | 2022-10-01 |
| publisher | Universitas Nahdlatul Ulama Surabaya |
| record_format | Article |
| series | Indonesian Journal of Medical Laboratory Science and Technology |
| spelling | doaj.art-d2d280ce1ccf49fabae5ab0cb0f233c52022-12-22T04:17:06ZengUniversitas Nahdlatul Ulama SurabayaIndonesian Journal of Medical Laboratory Science and Technology2684-67482656-98252022-10-014210.33086/ijmlst.v4i2.3027Validation of Rapid Antibody (IgM – IgG) Test Kit for SARS-CoV-2 Infection in Surabaya, IndonesiaMuseyaroh Museyaroh0Puspa Wardani1Aryati Aryati2Evy Diah Woelansari3Health Polytechnic Ministry of Health Surabaya, Surabaya, East Jawa, IndonesiaDepartment of Clinical Pathology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, IndonesiaDepartment of Clinical Pathology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, IndonesiaHealth Polytechnic Ministry of Health Surabaya, Surabaya, East Jawa, Indonesia At the beginning of the Corona Virus Disease 2019 (COVID-19) pandemic, rapid test examinations were widely used as a screening for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. The purpose of this examination was to detect SARS-CoV-2 IgM/IgG antibodies in the patient's body. One of these tests uses the immunochromatographic method. This study aims to determine the validity of immunochromatography. The study was conducted from August to September 2020. The sample used in this study was 100 patients. The research was conducted at Husada Utama Hospital Surabaya, Indonesia. According to the study's findings, the Zybio brand reagent kit has an accuracy of 85%, a sensitivity of 82%, a specificity of 88%, a positive predictive value of 87%, and a negative predictive value of 83%. In the group of patients who experienced clinical symptoms, < 7 had a sensitivity of 50%, specificity of 88%, positive predictive value of 60%, negative predictive value of 83%, and accuracy of 77.94% while the group of patients experiencing clinical symptoms > 7 days, had a sensitivity value of 100 %, specificity of 88%, positive predictive value of 84%, negative predictive value of 100%, and accuracy of 92.68%. Based on these results, the conclusion is that the Zybio brand reagent kit has a relatively high sensitivity, specificity, positive predictive value, negative value, and sample accuracy. In the group with clinical sensitivity < 7 days, the positive predictive value and accuracy are lower than the sample group with clinical symptoms > 7 days but have the same specificity. https://journal2.unusa.ac.id/index.php/IJMLST/article/view/3027ICTPCRSARS-CoV-2Validation |
| spellingShingle | Museyaroh Museyaroh Puspa Wardani Aryati Aryati Evy Diah Woelansari Validation of Rapid Antibody (IgM – IgG) Test Kit for SARS-CoV-2 Infection in Surabaya, Indonesia Indonesian Journal of Medical Laboratory Science and Technology ICT PCR SARS-CoV-2 Validation |
| title | Validation of Rapid Antibody (IgM – IgG) Test Kit for SARS-CoV-2 Infection in Surabaya, Indonesia |
| title_full | Validation of Rapid Antibody (IgM – IgG) Test Kit for SARS-CoV-2 Infection in Surabaya, Indonesia |
| title_fullStr | Validation of Rapid Antibody (IgM – IgG) Test Kit for SARS-CoV-2 Infection in Surabaya, Indonesia |
| title_full_unstemmed | Validation of Rapid Antibody (IgM – IgG) Test Kit for SARS-CoV-2 Infection in Surabaya, Indonesia |
| title_short | Validation of Rapid Antibody (IgM – IgG) Test Kit for SARS-CoV-2 Infection in Surabaya, Indonesia |
| title_sort | validation of rapid antibody igm igg test kit for sars cov 2 infection in surabaya indonesia |
| topic | ICT PCR SARS-CoV-2 Validation |
| url | https://journal2.unusa.ac.id/index.php/IJMLST/article/view/3027 |
| work_keys_str_mv | AT museyarohmuseyaroh validationofrapidantibodyigmiggtestkitforsarscov2infectioninsurabayaindonesia AT puspawardani validationofrapidantibodyigmiggtestkitforsarscov2infectioninsurabayaindonesia AT aryatiaryati validationofrapidantibodyigmiggtestkitforsarscov2infectioninsurabayaindonesia AT evydiahwoelansari validationofrapidantibodyigmiggtestkitforsarscov2infectioninsurabayaindonesia |